Biotech Business Oncopeptides starts commercialization of Pepaxti in Europe Malin Otmani October 4, 2022
Biotech Business Hansa Biopharma announces temporary marketing authorization in Switzerland Malin Otmani May 13, 2022
Agreement 1129 Views Orion and Amneal enter strategic partnership Malin Otmani January 4, 2023 Orion Corporation has signed a…
Biotech Business 329 Views Oncopeptides starts commercialization of Pepaxti in Europe Malin Otmani October 4, 2022 The company has submitted the…
New Market 445 Views Orientation Marketing opens office in Finland Malin Otmani September 6, 2022 Orientation Marketing has opened a…
MedTech Business 1771 Views Senzime receives FDA 510k-clearance Malin Otmani August 19, 2022 The company’s TetraGraph-system has now…
New Market 1499 Views AstraZeneca’s Enhertu approved in the US Malin Otmani August 10, 2022 AstraZeneca and Daiichi Sankyo’s Enhertu…
Business article 1123 Views Business Q&A: The four Ps of market entry NLS July 4, 2022 Patent, pricing, production, and partnerships…
New Market 724 Views NorthX Biologics expands to cell therapy Malin Otmani June 21, 2022 NorthX Biologics is expanding into…
Biotech Business 1797 Views BioLamina opens an office in Boston Malin Otmani June 15, 2022 BioLamina has announced plans to…
Biotech Business 589 Views Immunovia Inc achieves Clinical Laboratory Licensure Malin Otmani May 18, 2022 The Rhode Island Department of…
Biotech Business 417 Views Hansa Biopharma announces temporary marketing authorization in Switzerland Malin Otmani May 13, 2022 Hansa Biopharma has announces that…
New Market 785 Views Novo Nordisk’s Ozempic 2.0 mg approved in the US Malin Otmani April 4, 2022 Novo Nordisk has announced that…
New Market 479 Views InDex Pharmaceuticals prepares for commercialization of cobitolimod Malin Otmani April 1, 2022 InDex Pharmaceuticals Holding is planning…
New Market 621 Views AstraZeneca’s Ondexxya approved in Japan Malin Otmani March 29, 2022 Ondexxya has been approved in…
New Market 996 Views AstraZeneca’s Tezspire approved in the US Malin Otmani December 20, 2021 AstraZeneca and Amgen’s Tezspire has…
Biotech Business 1211 Views FDA approves Calliditas’ TARPEYO Malin Otmani December 16, 2021 Calliditas Therapeutics has announced that…
New Market 669 Views AstraZeneca’s Saphnelo approved in Japan for SLE Malin Otmani September 28, 2021 Saphnelo (anifrolumab) has been approved…